Suchen

Ihre Ergebnisse

Anzeige: 10 von 17 Ergebnissen

In September 2020, as part of the fight against cancer and to protect the health of workers in a number of industries, the European Commission proposed to amend the Carcinogens and Mutagens Directive (Directive 2004/37/EC), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. On 16 December 2021, after interinstitutional negotiations, the Council and the European Parliament reached a provisional agreement ...

Im Rahmen des Kampfes gegen Krebserkrankungen und zum Schutz der Gesundheit von Arbeitnehmern in einer Reihe von Branchen wird die Richtlinie über Karzinogene und Mutagene zum vierten Mal aktualisiert. Mit einer im Trilog erzielten Einigung über den Vorschlag werden neue Expositionsgrenzwerte für eine Reihe gefährlicher Stoffe festgelegt. Das Europäische Parlament wird voraussichtlich auf seiner Plenartagung im Februar über die vorläufige Einigung abstimmen.

Schutz von Arbeitnehmern vor Asbest

Auf einen Blick 13-10-2021

Asbest ist trotz seines EU-weiten Verbots im Jahr 2005 eine der Hauptursachen für arbeitsbedingte Krebserkrankungen. Asbestbedingte Risiken bestehen nach wie vor und werden im Zusammenhang mit der Renovierungswelle des europäischen Grünen Deals, die dazu beitragen soll, Gebäude für ein klimaneutrales Europa fit zu machen, ein Gesundheitsrisikofaktor sein. Ein legislativer Initiativbericht mit Vorschlägen für eine „Europäische Strategie zur Beseitigung von Asbest (ESRAA)“ wird voraussichtlich während ...

Protecting workers from asbestos

Eingehende Analyse 29-03-2021

Asbestos is responsible for more than half of the deaths from occupational cancer in the world. Since 2005 Asbestos is banned in Europe. The risks remain, because of the maintenance or demolition work on older buildings and their renovation (increasing energy efficiency) result in substantial exposure to asbestos and many people still work and live in asbestos contaminated buildings.

The impact assessment (IA) defines clearly the problem and its underlying drivers. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable and/or justified. However, the IA would have benefited from providing greater clarity on those components that were either included in (short-term exposure limit values) or excluded (biological limit values) from the preferred options. The analysis of impacts focuses on their economic and social dimension, mainly ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

Die Europäische Kommission hat ein in mehrere Phasen gegliedertes Verfahren zur Änderung der Richtlinie 2004/37/EG (Richtlinie über Karzinogene und Mutagene) eingeleitet, um den Anwendungsbereich der Richtlinie zu erweitern und Arbeitsplatzgrenzwerte für verschiedene krebs- oder mutationserregende chemische Wirkstoffe aufzunehmen bzw. zu überarbeiten. Im dritten Vorschlag zur Änderung der Richtlinie geht es um fünf weitere Wirkstoffe. Die in Trilog-Verhandlungen erzielte Einigung über den Vorschlag ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...